News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Argos Therapeutics, Inc. (ARGS) CSO Dr. Charles Nicolette To Join Panel Discussion On Challenges In Clinical Trial Development At The Society Of Gene & Cell Therapy Annual Meeting



5/20/2014 9:45:24 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DURHAM, N.C., May 19, 2014 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (Nasdaq:ARGS), a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, today announced that company chief scientific officer and vice president of research and development Charles A. Nicolette, Ph.D., will participate in a panel discussion highlighting key issues in late stage development in gene and cell therapy. The discussion, entitled "Things you wish you'd known early on your way to late stage development," will take place on Friday, May 23, 2014, during the 17th Annual Meeting of the American Society of Gene & Cell Therapy at the Marriott Wardman Park Hotel in Washington, DC.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES